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Abstract
Asthma is a global health problem with increasing prevalence. The airway epithelium is the initial barrier against
inhaled noxious agents or aeroallergens. In asthma, the airway epithelium suffers from structural and functional
abnormalities and as such, is more susceptible to normally innocuous environmental stimuli. The epithelial structural
and functional impairments are now recognised as a significant contributing factor to asthma pathogenesis. Both
genetic and environmental risk factors play important roles in the development of asthma with an increasing number
of genes associated with asthma susceptibility being expressed in airway epithelium. Epigenetic factors that regulate
airway epithelial structure and function are also an attractive area for assessment of susceptibility to asthma. In this
review we provide a comprehensive discussion on genetic factors; from using linkage designs and candidate gene
association studies to genome-wide association studies and whole genome sequencing, and epigenetic factors; DNA
methylation, histone modifications, and non-coding RNAs (especially microRNAs), in airway epithelial cells that are
functionally associated with asthma pathogenesis. Our aims were to introduce potential predictors or therapeutic
targets for asthma in airway epithelium. Overall, we found very small overlap in asthma susceptibility genes identified
with different technologies. Some potential biomarkers are IRAKM, PCDH1, ORMDL3/GSDMB, IL-33, CDHR3 and CST1 in
airway epithelial cells. Recent studies on epigenetic regulatory factors have further provided novel insights to the field,
particularly their effect on regulation of some of the asthma susceptibility genes (e.g. methylation of ADAM33).
Among the epigenetic regulatory mechanisms, microRNA networks have been shown to regulate a major
portion of post-transcriptional gene regulation. Particularly, miR-19a may have some therapeutic potential.
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Background
Asthma affects people of all ethnicities and ages and
there has been a substantial increase in the prevalence of
asthma over the past few decades, with current estimates
of approximately 300 million people suffering from the
disease worldwide [1]. Asthma is characterised by cough-
ing, shortness of breath, chest tightness and wheezing,
often triggered by exposure to allergens and foreign patho-
gens [1]. The initial response consists primarily of airway
smooth muscle constriction and airway inflammation
(oedema, inflammatory cell infiltration, increased airway
secretions). Whereas more chronic responses such as
structural remodelling of the airway including smooth
muscle and sub-mucosal gland hyperplasia and hyper-
trophy, extracellular matrix (ECM) deposition and angio-
genesis are generally thought to occur in parallel with
inflammatory responses [1].
The airway epithelium is the interface between the res-
pirable environment and the sub-mucosa and acts as the
first defence line against inhaled noxious agents and
aeroallergens [2]. The epithelium of conducting airways
is pseudo-stratified and consists of ciliated columnar epi-
thelial cells, goblet cells, intermediate columnar epithe-
lial cells, side population cells, serous cells, and basal
cells [3]. The epithelium of asthmatics presents several
structural and functional abnormalities, including a
greater proportion of resident stem cells and basal cells,
goblet-cell hyperplasia and excessive mucus production
* Correspondence: fatemeh.moheimani@newcastle.edu.au
1School of Biomedical Sciences and Pharmacy, Faculty of Health and
Medicine, HMRI building, The University of Newcastle, Callaghan, NSW 2308,
Australia
2Priority Research Centre for Healthy Lungs, Hunter Medical Research
Institute, The University of Newcastle, New South Wales, Australia
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Moheimani et al. Respiratory Research  (2016) 17:119 
DOI 10.1186/s12931-016-0434-4
as well as fewer ciliated cells compared to healthy individ-
uals, suggesting dysregulated differentiation [4, 5]. The
epithelial abnormalities are associated with increased
susceptibility to oxidant-induced stress, aberrant cyto-
kine and ECM release [6], mitotic dyssynchrony [7]
and a deficient innate immune response [8–10]. These
abnormalities also affect epithelial repair and regener-
ation processes after injury, leading to defective main-
tenance of the epithelial barrier and its normal
function [2, 11, 12].
Both genetic susceptibility and environmental risk factors
influence asthma [13]. Genetic studies have progressed
from using linkage designs and candidate gene association
studies to genome-wide association studies (GWAS) [14]
and whole genome sequencing (WGS) [15], and detected
different genes associated with asthma susceptibility. Sev-
eral of the recent GWAS have shown to have a significant
epithelial contribution, which also segregates away from al-
lergy/atopy. Furthermore, different environmental chal-
lenges (such as smoking, air pollution, and microbial
exposures) can affect gene expression through epigenetic
regulation. Epigenetic factors are an important regulator of
gene transcription, that do not influence gene sequence
[16]. Epigenetic mechanisms include DNA methylation,
histone modifications, and regulation by non-coding RNAs,
especially microRNAs (miRNAs). This review will focus on
identifying genetic and epigenetic candidates in airway
epithelium, which are functionally associated with asthma
and may act as predictors or therapeutic targets.
Asthma susceptibility genes in airway epithelium
Early genetic studies relied on positional cloning in com-
bination with linkage analysis leading to detection of
genes associated with asthma expressed in airway epithe-
lium including A disintegrin and metalloprotease 33
(ADAM33), GPRA, protocadherin-1 (PCDH1), Serine
protease inhibitor Kazal type-5 (SPINK5), IL-1 receptor
associated kinase-M (IRAKM), Dipeptidyl-peptidase 10
(DPP10) and HLA-G genes (Table 1) [17–31]. ADAM33
on chromosome 20p13, was the first asthma susceptibil-
ity gene discovered [17]. ADAM33 protein is expressed
in many cells including the airway epithelium [18], fibro-
blasts and smooth muscle cells [17, 18, 32] and is known
as a membrane-anchored metalloprotease with diverse
functions, including shedding of cell-surface proteins
such as cytokines and cytokine receptors [17]. ADAM33
has be associated with airway remodelling and bronchial
hyperresponsiveness (BHR) through epithelial–mesen-
chymal trophic unit (EMTU), leading to proliferation of
biosynthetically active fibroblasts, myofibroblasts and
smooth muscle [17]. PCDH1 is located on chromosome
5q31-q33 and encodes the protocadherin-1 protein
[22, 23]. The expression of PCDH1 is aligned with the
apical adhesion complex expression in airway epithelial
Table 1 Asthma susceptibility genes identified by positional cloning and genome-wide association (GWAS) in airway epithelium
Positional cloning
Chromosome Gene Function Reference
20p13 ADAM33 Airway remodelling and BHR [17]
5q31-q33 PCDH1a Airway remodelling and BHR [22–24]
2q14-32 DPP10 BHR [27–29]
6p21 HLA-G BHR [30, 31]
7p15-p14 GPRA/NPSR1/GPR154 Cell homeostasis [19–21]
5q31-35 SPINK5/LEKTI Protective against allergen/inflammation [25]
12q13-24 IRAKMb Inflammation [26]
Genome-wide association (GWAS) and associated SNP
Chromosome SNP Gene Function References
2 rs3771166 IL1RL1 and
IL18R1
Alarmin to alert the immune system after epithelial cell damage
during trauma or infection
[45, 50]
6 re9273349 HLA-DQ Recognition of non-self antigens [13]
9 rs1342326 IL33+ Alarmin [13, 50]
15 rs744910 SMAD3 TGF-β1 signaling and response to respiratory viral infection [50, 57–59]
17 rs2305480 ORMDL3b+
GSDMBb+
BHR
Epithelial cell homeostasis
[13, 64, 66–68]
5 rs1837253 TSLP+ Epithelial cell homeostasis and improving wound healing-Protective
role against asthma
[42, 43, 71–74]
aAdult and children
bEarly onset
+common between different ethnic group
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cells hence association of PCDH1 with asthma is proposed
to be through epithelial structural defects leading to BHR
[22, 23] and is IgE independent [24]. Dysregulation of
PCDH1 expression in asthma also leads to impaired differ-
entiation of epithelial cells [23]. Another gene is DPP10
which shown to preferentially expressed in the epithelium
of asthmatics [27]. DPP10, is located on 2q14-32 and en-
codes the di-peptidyl peptidase like 10 protein, which un-
like other members of DPP family is unable to cleave the
terminal of dipeptides from cytokines and chemokines
[27, 28]. These suggest other potential mechanisms for
DPP10 association with asthma. In the nervous system,
DPP10 has been shown to modulate the electrophysio-
logical properties, cell-surface expression and subcellular
localisation of voltage-gated potassium channels [33].
Considering the important role of potassium ion channels
in asthma [34], DPP10 may also be involved in this
process although this requires further investigation. Fur-
thermore, Zhou et al. reported the association of DPP10
with BHR in Chinese population [29]. HLA-G on chromo-
some 6p21 is also expressed highly in bronchial epithelial
cells of asthmatics and is associated with BHR [30].
HLA-G inhibits the effecter function of T cells and nat-
ural killer (NK) cells [35]. Three miRNAs; miR-148a,
miR-148b, and miR-152 have been reported to affect
HLA-G expression, suggesting that miRNA mediated
mechanisms may contribute to the impact of HLA-G
on asthma risk [31].
Other studies detected GPRA (also known as Neuro-
peptide S Receptor 1; NPSR1, and GPR154) on chromo-
some 7p15-p14 [19–21]. Both GPRA, which belongs to
the G protein-coupled receptor family, and its agonist,
Neuropeptide S (NPS) are co-expressed in bronchial epi-
thelium and specific activation of the GPRA-A isoform
with NPS inhibits cell growth [19, 20]. Since the balance
between epithelial cell proliferation and regeneration is
dysregulated in asthmatics [4, 36], GPRA likely plays an
important role in the pathogenesis of disease [19, 20].
Further studies identified the SPINK5 gene on chromosome
5q31-35 which encodes a multidomain serine protease
inhibitor known as lympho-epithelial Kazal-type-related
inhibitor (LEKTI). LEKTI has been shown to be a major
physiological inhibitor of multiple serine proteinases, in-
cluding the exogenous serine proteases trypsin, plasmin,
subtilisin A, cathepsin G and neutrophil elastase [37].
SPINK5 is essential in the epidermal barrier function
through regulating protease activity [38] and LEKTI plays
a crucial role in skin homeostasis by selectively inhibiting
human kallikrein-related peptidase genes including, KLK5,
KLK7 and KLK14 [39]. LEKTI may therefore protect the
epithelium against allergens or inflammatory related pro-
teases. However, the exact function of SPINK5 in airway
epithelium remains to be elucidated. Another asthma sus-
ceptibly gene is IRAKM, which is located on chromosome
12q13-24. IRAK-M regulates NF-kB and inflammation via
suppressing Toll-like receptor/IL-1R pathways. When
IRAK-M function is hampered, overproduction of inflam-
matory cytokines in the lung in response to infection/aller-
gens may result in a Th2-mediated allergic response and/
or Th1-dependent exacerbation of asthma symptoms [26].
Further technological advances led to GWAS [40], and
associated single nucleotide polymorphisms (SNPs) [13],
which detected a completely different set of genes; inter-
leukin (IL) 1 receptor-like 1 (IL1RL1) and IL18 receptor
1 (IL18R1), IL33, HLA-DQ, SMAD3, thymic stromal
lymphopoietin (TSLP), ORM1-like 3 (ORMDL3) and
gasdermin B (GSDMB) as asthma susceptibility genes
expressed in airway epithelium (Table 1) [13, 14, 41–43].
IL1RL1 and IL18R1 contain SNP rs3771166 on chromo-
some 2 [13, 44]. IL1RL1 (also known as T1, ST2, DER4,
or FIT-1) belongs to the IL-1 superfamily and is the re-
ceptor for IL-33 [45]. IL33 with SNP rs1342326 located
on chromosome 9 is also associated with atopic asthma
[13, 46, 47]. IL-33 possesses potent transcriptional-
repressive properties and is constitutively expressed in
epithelial cells [48]. It has been shown that IL-33 activates
NF-kB and mitogen-activated protein (MAP) kinases, and
induces production of T-helper (Th) 2-associated cyto-
kines, including IL-4, IL-5, and IL-13 [49]. In this context,
IL-33 functions as a prototypical ‘alarmin’ and an en-
dogenous ‘danger’ signal to alert the immune system after
epithelial cell damage during trauma or infection [50] and
plays an essential role in pro-inflammatory pathway in
asthma [13]. IL18R1 encodes the receptor for IL-18 [45].
IL-18 modulates innate and adaptive immune responses
by increasing interferon (IFN)-γ production by Th1 and
natural killer (NK) cells or by activating IgE production
and Th2 cell differentiation [45].
Another candidate gene detected by GWAS is HLA-DQ
region of the major histocompatibility (MHC) gene lo-
cated on chromosome 6, which contains SNP rs9273349
[51]. The airway epithelium expresses MHC class II; a het-
erodimer molecule that consists of an α- and a β-chain in
one of three HLA loci: DR, DP and DQ [52], on their
surface [53]. Immune response to allergens is also re-
lated to specific HLA-DR and DQ haplotypes [13], and
is associated with asthma induced by house dust mite,
aspirin, soybean, and occupational triggers [54]. How-
ever, the exact role of HLA-DQ in airway epithelium
still remains unclear.
SMAD3, with SNP rs744910 located on chromosome
15, is another asthma susceptibility gene [13]. SMAD3 is
an essential signal transducer in transforming growth
factor (TGF)-β signalling, which is elevated in airway
epithelial cells of some asthmatics [55]. TGF-β1 induces
epithelial–mesenchymal transition (EMT) in airway
epithelial cells via a SMAD3-dependent transcription
factor snail1 (SNAI1) which transcriptionally supresses
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E-cadherin [36, 56]. Furthermore, the TGF-β/SMAD3
pathway play essential roles in the airway epithelial re-
sponse to respiratory viral infection [57–59], including
increasing replication of both respiratory syncytial virus
[57, 58] and rhinovirus [59].
Among asthma susceptibility genes, ORMDL3 and
GSDMB, with SNP rs2305480 at chromosome 17q21,
are associated with childhood asthma [60]. ORMDL3 is
a member of a gene family that encodes transmembrane
proteins anchored in the endoplasmic reticulum of airway
epithelial cells, predominantly [60, 61]. Allergens induce
ORMDL3 expression in airway epithelium leading to in-
creased expression of asthma-associated chemokines,
metalloproteases and the unfolded protein response
(UPR), which may implicate the potential link between
ORMDL3 and asthma [61]. ORMDL regulates ORM
protein expression in airway epithelial cells, which is
induced in response to allergen challenge [62]. ORM
proteins are important homeostatic regulators of sphingo-
lipid metabolism [63], which is associated with the patho-
genesis of asthma [64]. Sphingolipids are pivotal in
maintenance of cell structure and signaling pathways in
physiological and pathological processes; e.g. proliferation,
apoptosis and migration [63, 65] and have been shown to
contribute to BHR in experimental models of asthma [66].
Further meta-analysis has showed that SNP rs7216389 in
the ORMDL3 may play essential and independent predis-
posing roles in ethnically diverse populations for both
childhood and adult-onset asthma [41]. GSDMB is adja-
cent to ORMDL3 and is a member of gasdermin family
that encodes gasdermin B protein which has roles in
secretory pathways, epithelial cell differentiation, cell cycle
control and apoptosis [67, 68]. Furthermore, there are sev-
eral response elements for interferon regulatory factors
present in the GSDMB promoter region and epithelial
interferon-α induces GSDMB gene and protein in human
nasal epithelial cells, in vitro [69]. GSDMB has been
proposed to be the causative gene associated with
asthma [70].
Among the candidate genes identified by GWAS, TSLP
on chromosome 5 plays protective roles against the risk
of asthma, atopic asthma and BHR across various ethnic
groups [42, 43, 71–73]. The rs1837253 SNP may be dir-
ectly involved in the regulation of TSLP secretion in
primary nasal epithelial cells [42]. TSLP is an IL-7 like
cytokine that induces myeloid dendritic cells to stimu-
late the differentiation of naive CD4+ T cells to Th2
cells. TSLP mRNA and protein are highly expressed in
the asthmatic airway epithelium [72–74]. TSLP has
been shown to induce bronchial epithelial cell prolifer-
ation and increases repair responses to injury through
IL-13 production [74].
Collectively these genes are important in epithelial
cell damage, innate and adaptive immunity, and airway
inflammation, which are pivotal in the pathology of
asthma. Furthermore, some of the products associated
with these genes can determine the phenotype of asthma.
For instance, the level of IL-33 is highly elevated and
widely distributed in bronchial epithelial cells of moderate
and severe asthmatics [48]. IL-18 may also contribute to
asthma exacerbations in mild and moderate asthmatics
through activation of immunologic responses [51]. Given
the relationship to asthma endotypes, these genes may in-
dicate pathways for therapeutic intervention. In fact, Phase
II trials are currently proceeding using an anti-TSLP anti-
body; AMG 157 from Amgen Corp., to neutralise the
TSLP cytokine for the treatment of allergic diseases as
asthma [75].
Notably, only a few genes, such as IL33 and TSLP, are
shared among all asthmatics [42, 76, 77] and may play
roles as potential biomarkers. Furthermore, while the
association of the 17q21 locus (ORMD/GSDMB) with
asthma is the most consistent finding from different
studies, there is limited evidence to validate certain
SNPs [14]. Integrative genomics defined as identification
of causal genes and variants, with improved statistical
power, is a promising new approach. By using gene ex-
pression as a phenotype and examining how DNA
polymorphisms contribute to both gene expression
(expression quantitative trait loci; eQTLs) and disease
phenotypes, true causal relationships can be discovered
[78–80]. Although GWAS have identified loci that are
strongly associated with asthma, the molecular mecha-
nisms underlying these associations rely on other technol-
ogy such as eQTLs [78].
One eQTL study showed that chromosome 17q21,
which contained strong GWAS hits, also regulates ex-
pression levels of cyclin-dependent kinase 12 (CDK12),
protein phosphatase 1 regulatory subunit 1B (PPP1R1B),
titin-cap (TCAP) and StAR-related lipid transfer
(START) domain containing 3 (STARD3) genes in the
airway epithelium [78]. CDK12 is a member of the
cyclin-dependent kinase (CDK) family, which are
serine/threonine kinases regulating cell cycle progression
[78, 81]. Airway epithelial cells from asthmatics overexpress
the CDK inhibitor; p21waf [82], which may explain the ab-
normal repair responses of the airway epithelium of asth-
matics after wounding [82]. However, the role of TCAP,
PPP1R1B, STARD3 in asthma are still unknown [78]. Fur-
thermore, epithelial eQTL detected Cystatin SN (CST1) on
chromosome 20p11.21, which contains SNP rs16856186
[78]. CST1 may neutralise cystatin C; a potent cathepsin
B inhibitor, and increase cell proliferation [83]. CST1 is
expressed differentially in airway cells of asthmatics
with exercise-induced bronchoconstriction (EIB) compared
to asthmatics without EIB [84]. eQTL also confirmed
cadherin-related family member 3 (CDHR3) gene, as an
epithelial susceptibly gene for severe exacerbations in
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childhood asthma [78, 85]. CDHR3 encodes a hemophilic
cell adhesion molecule, which may be involved in maintain-
ing cell integrity by forming cell-cell junctions. Further-
more, functional disruption of CDHR3 has been reported
in human rhinovirus-induced asthma exacerbation [86].
Also, epithelial eQTL supported SPINK5 as an asthma sus-
ceptibility gene [86], as described earlier.
It is also essential to note that in a disease as complex
as asthma, it is unlikely that one or a few functional gene
variants will be responsible for all pathophysiological
events. While GWAS have been useful and continue to
identify novel genes for allergic diseases through in-
creased sample sizes and phenotype refinement, further
approaches to integrate analyses of rare variants, eQTL
approaches, and epigenetic mechanisms will likely lead
to greater insight into the genetic basis of the disease.
The advent of whole genome sequencing (WGS), which
includes copy number variants (CNVs) and low-frequency
variants, has been proposed to overcome the drawbacks of
the earlier technologies [15, 76]. CNVs, which are genetic
variants including the deletion or duplication of more than
50 bp of gene sequence [15], are one the most recent ad-
vances to detect asthma susceptibility genes. Recently, an
association between a 6 kbp deletion in an intron of
NEDD4L with increased risk of asthma was reported but
only in Hutterites [15]. NEDD4L is expressed in bronchial
epithelial cells, and NEDD4L knockout mice showed se-
vere airway inflammation and mucus accumulation [15].
To adequately assess the entire genome, a large number
of genetic polymorphisms (250,000 to 1 million) is required
and the number of polymorphisms will vary between stud-
ies due to different levels of linkage disequilibrium [14].
Currently, WGS is neither affordable nor feasible on the
large number of individuals to acquire sufficient power for
detecting associations with asthma [15].
Effect of environmental exposure on asthma
Environmental factors play essential roles in asthma aeti-
ology. The increase in the prevalence of asthma world-
wide during recent decades, the substantial variations in
populations with a similar racial and ethnic background
but exposed to different environmental stimuli, and the
significant increase in the frequency of occupational
asthma are all pointing out toward the important role of
environmental factors [87].
Environmental stimuli affecting asthma are categorised
to outdoor and indoor factors. Outdoor stimuli that
trigger or exacerbate asthma include microbial and viral
pathogens, airborne particulates, ozone, diesel exhaust
particles, pollens, outdoor moulds, environmental tobacco
smoke, cold air, and humidity [87, 88]. Indoor environ-
mental factors include allergens derived from dust mites,
cockroaches, mice and pets which has been shown to in-
duce airway inflammation; particles generated from indoor
burning of tobacco, wood, and biomass; and biological
agents such as indoor endotoxin, products from gram-
positive bacteria, and 1,3-β-glucans from moulds [87, 88].
In particular relation to asthma susceptibility, the ex-
posure to specific environmental factors can play key
factor in the induction or suppression of asthma-related
genes. The main areas of studies in regards to the impact
of gene-environment interactions on asthma development
and pathogenesis have been so far related to smoking, air
pollution, and microbial exposures. Maternal smoking is
one of the major risk factor for asthma in offspring. Ma-
ternal smoking substantially enhances the strength of the
linkage signal on chromosome 5q31–34 to asthma in the
children [89, 90]. Furthermore, polymorphic variation
in candidate genes known to be involved in asthma, for
example TNF-308 and glutathione-S-transferase M1
(GSTM1; involved in detoxification of oxidative stress
and lung function growth in children), are predictors of
BHR to passive smoking [89, 91]. The most well-known
interaction between environmental factors and gene is
between endotoxin with Toll like receptor (TLR)-4 with
further impact on adaptive immune response, epithelial
and smooth muscle cells through NF-kB. Polymorph-
ism in TLR-4 is related to asthma and it is proposed
that the other TLRs (e.g. TLR-9 and -3) present the
similar polymorphic associations with other environ-
mental stimuli, such as CpG methylation of TLR-9 and
double-stranded RNA (dsRNA) for TLR-3 [89, 92].
These reports point out to the importance of early life
environmental factors, such as passive smoking, pollu-
tant exposure and viral infections, as a perverse factor
on the developing asthma in childhood.
However little is known about the effect of
environmental-gene interactions in airway epithelium
of asthmatics. It has been shown that particulate matter
with a diameter of <10 μm diameter (known as PM10) in-
creases HAT activity and the level of acetylated histone 4
(H4) through oxidative stress. PM10 induced histone
acetylation is associated with promoter region of the IL-8
resulting in increased IL-8 gene and protein release from
alveolar epithelial (A549) cells [93]. Interestingly, butyrate;
a fermentation product of intestinal bacteria, also showed
to enhance histone acetylation by inhibition of HDAC
enzymes leading to an increase in gene expression of
inflammatory cytokines in intestinal epithelial cells [94].
Cigarette smoke-induced oxidative stress also reduces
HDAC2 and increases cytokines expression in alveolar
macrophages [95] but the effect on airway epithelium is
yet to be determined.
Most importantly, many of the indoor and outdoor
asthma triggers also have demonstrable reprogramming
effects on the immature airway during early life, leading
to altered asthma risk in later life. Asthma hence is not a
homogeneous disease but a condition influenced by
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interactions between genetic and environmental factors
through epigenetic mechanisms that influence gene
expression.
Epigenetic regulatory factors in airway epithelium
Environmental challenges can affect gene expression
through epigenetic mechanisms. Epigenetics is described
as a heritable regulation of gene transcription that does
not require alterations in gene sequence [16]. Epigenetic
changes may form stable heritable changes in gene ex-
pression and in a tissue-specific fashion [96, 97]. Par-
ticularly, epigenetic regulation affects gene expression
through three main mechanisms, including DNA modi-
fications, histone modifications, and non-coding RNAs
(Fig. 1 and Table 2).
DNA modifications
Modification of DNA occurs through addition or re-
moval of small covalent molecules such as methyl or
acetyl groups. DNA methylation occurs when methyl
groups are added by a DNA methyltransferase (DNMT),
onto cytosine nucleotides that are followed by guanine
residues (CpG sites). Gene promoters are relatively rich
in CpG sites which are known as CpG islands. DNA
methylation can lead to gene expression silencing through
formation of 5-methyl-cytosine (5mC) [98].
Recent studies have characterised a number of DNA
methylation signatures in epithelial cells of asthmatics,
including cytokeratin 5 (KRT5) [99], signal transducer and
activator of transcription 5A (STAT5A) [99], cysteine-rich
protein 1 (CRIP1) [99], arginase 2 (ARG2) [100], IL-6
[98], inducible nitric oxide synthase (iNOS) [98] and
ADAM33 [101] (Table 2).
KRT5 is a marker of basal cells and its expression is in-
creased in the epithelium of asthmatics [5, 36]. In asthmatic
children, KRT5 exhibits reduced methylation resulting in
increased expression of this gene [97, 99]. Increased KRT5
may hence be associated with dysregulated epithelium dif-
ferentiation. The STAT5A transcription factor is activated
by different pro-Th2 cytokines (e.g. IL2, IL7, or TSLP) sug-
gesting its significant role in promoting Th2 cell differenti-
ation and responses [102] and epithelial cell proliferation
[103]. CRIP1 has been reported to play a role in cell motil-
ity, adhesion, and structure through interaction with the
cytoskeletal protein actin [104] and also translocates to the
nucleus to facilitate protein interactions important for tran-
scriptional regulation [105]. The promoters of STAT5A and
CRIP1 are hyper-methylated in epithelium of asthmatic
children [99], resulting in decreased expression of STAT5A,
contrary to increased CRIP1 expression [99]. Further stud-
ies are therefore needed to understand the roles of STAT5A
and CRIP1 in epithelial function.
Fig. 1 Epigenetic regulatory factors in airway epithelium. a DNA methylation; white circles represent unmethylated CpGs that induces gene
expression (e.g. KRT5) while black circles represent methylated CpGs that suppresses gene expression (e.g. STAT5A). b Histone acetylation; green
circles refer to acetylated histone tail that stimulate gene expression (e.g. ΔNp63) while red circles indicate free histone tails that suppressed gene
expression. c Noncoding RNA; miRNAs affect gene expression by either RNA degradation or translational inhibition. miRNAs hence (e.g. miR-19a)
may suppress mRNA expression (e.g. TGF-β receptor 2)
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ARG2, IL-6 and iNOS are three methylated genes that
have been related to fractional exhalation of nitric oxide
(FeNO) in asthmatic children [98, 100, 106]. Methylation
of the ARG2 promoter in asthmatic children is associ-
ated with reduced FeNO [100]. However, asthmatic
children with lower DNA methylation of the IL-6 and
iNOS promoters in nasal epithelial cells had higher air-
way inflammation, as measured by increased FeNO
[98]. Therefore, further investigation is required to de-
termine the underlying biological mechanisms driving
the association of these DNA methylations with FeNO
and whether children with different degrees of asthma
severity and symptom management have different levels
of DNA methylation.
Furthermore, hyper-methylation on ADAM33 in bron-
chial epithelial cells is strongly associated with BHR,
irrespective of asthma status [101]. This is in contrast
to ADAM33 hypo-methylation in fibroblasts, which is
speculated to be involved in airway remodelling [107].
This highlights the importance of cell specific epigenetic
changes, as well as the potential challenges in developing
novel therapeutics.
Recently, DNA methylation has been shown to occur
in airway epithelial cells isolated from asthmatics after a
single 24 h exposure to IL-13 [108]. Intriguingly, areas
of methylation were mainly adjacent to asthma suscepti-
bility genes and in particular genes related to fibrotic
and inflammatory pathways (e.g. neutrophil cytosolic fac-
tor 2; NCF2, and MMP14) [108]. Global and gene specific
methylation status in the airway epithelium however still
requires further investigation before potential targets can
be identified and trialled as therapies for asthma.
Histone modifications
The DNA of each cell is packaged into nucleosomes
where its 147 base pairs wrap around an octamer of four
core histone (H2A, H2B, H3, and H4). The covalent
alterations of the amino acid residues of core histone
N-terminal tails are essential for modification of the
chromatin structure and regulate gene expression. For
Table 2 Epigenetic regulatory factors associated with asthma in airway epithelial cells
DNA modification signatures
Gene Status Function References
KRT5a Hypo-methylation Epithelial homeostasis [97, 99]
STAT5Aa Hyper-methylation Immune system, Cell proliferation [99]
CRIP1a Hyper-methylation Epithelial homeostasis, transcription [99]
ARG2a Hyper-methylation Reduced FeNO [100]
IL-6a Hypo-methylation Increased FeNO [98]
iNOSa Hypo-methylation Increased FeNO [98]
ADAM33 Hyper-methylation BHR [101]
Histone modification signatures
HDAC/HAT Status Function References
H3K18 Acetylation Increases the expression of ΔNp63, EGFR and STAT6 affecting epithelial homeostasis [109]
HDAC2a De-acetylation Anti-inflammatory [112]
miRNA signatures
miRNA Status Function References
let-7fb Overexpressed unknown [121]
miR-487bb
miR-181cb
miR-203b Suppressed Targeting p63 and c-Abl [121–123]
miR-34/449 family Suppressed Targeting NOTCH1 mRNA and affecting cell homeostasis [125]
miR-18a Suppressed activation/signalling of IL-6 and IL-8 [129]
miR-27a
miR-128
miR-155
miR-19ac Overexpressed Targeting TGF-β receptor 2 mRNA and affecting cell homeostasis [130]
aChildren
bMild asthma
cSevere asthma
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example, the acetylation of lysine residues on histone
tails via histone acetyltransferases (HATs), generally re-
sults in increased gene transcription whereas removal of
the acetyl group via deacetylases (HDACs) leads to gene
suppression. In contrast, methylation of histone tails can
be both activating and suppressing depending on the par-
ticular residue. Methyl groups are added to lysine or argin-
ine residues by histone methyltransferases (HMTs) and
removed by histone demethylases (HDMs) [109, 110].
Increased HAT activity and reduced HDAC activity in
biopsies from mild asthmatics have been reported to
lead to the increased expression of multiple inflammatory
genes [111]. Interestingly, these activities may be partially
reversed by treatment with inhaled corticosteroids [111].
Furthermore, within the adult airway epithelium, elevated
histone H3 lysine 18 (H3K18) acetylation and histone H3
lysine 9 trimethylation (H3K9me3) have been shown in
asthmatics [109]. H3K18 acetylation increases the expres-
sion of ΔNp63, EGFR, and STAT6, which, are known to be
altered in the epithelium of asthmatics [109]. Very few
studies have investigated histone modifications in children
with asthma. In one study, passive cigarette smoke re-
duced HDAC2 activity and protein expression via PI3K
signalling in children with severe asthma. This is believed
to suppress the anti-inflammatory effects of corticosteroid
treatment [112] (Table 2).
Whether histone modifications in epithelial cells are
major contributors in conferring asthma susceptibility
and/or severity remains to be determined.
Non-coding RNAs
A number of classes of noncoding RNAs have been dis-
covered in mammalian cells including long non-coding
RNAs (lncRNAs), Piwi-interacting RNAs (piRNAs), and
miRNAs.
lncRNAs are non-protein coding RNA transcripts lon-
ger than 200 nucleotides. There are approximately
15,000 lncRNAs discovered so far although only a small
number of which have been shown to be biologically
relevant. piRNAs are small non-coding RNAs of 26–31
nucleotides long, predominantly found in spermatogenic
and ovarian cells [113]. Their functions have been linked
to both epigenetic and post-transcriptional gene silencing
[113]. piRNAs interact with piwi protein, a RNA-binding
protein, which degrades target mRNAs to prevent protein
translation [113]. There have been no studies that exten-
sively investigate profiles of lncRNAs and piRNAs in airway
epithelium of asthmatics. Only one study has shown that
piR30840 directly targets and degrades IL-4 mRNAs lead-
ing to inhibition of the development of Th2 T-lymphocytes.
Furthermore, the level of piR30840 is significantly reduced
in serum from patients with asthma [113].
miRNAs are proposed to control expression of 30–60 %
of human genes [114] and hence are crucial in most
biological and pathological processes including cell
proliferation, differentiation, apoptosis, carcinogenesis
and immune responses [115–117]. miRNAs are 20–24
nucleotides long and bind to the 3′ untranslated region
(UTR) of target mRNAs resulting in their degradation or
translational inhibition [118–120]. Currently, there are over
1000 miRNAs identified in miRbase (www.mirbase.org),
many of which have multiple binding partners and thus
affect multiple pathways [118]. miRNAs may modulate pro-
tein synthesis at both initiation and post-initiation of trans-
lation [118]. miRNAs have also been shown to up-regulate
some mRNA targets [120]. The balance between up- and
down-regulation of miRNA plays a pivotal role in cell cycle
and process of cell proliferation and regeneration, a process
that is dysregulated in asthmatic epithelium. miRNAs
are therefore interesting regulatory factors which may
contribute substantially to airway epithelium abnormal-
ities in asthmatics.
miRNA expression in epithelium of asthmatics
There are a limited number of studies examining miRNA
expression in epithelium of asthmatics or non-asthmatics
(Table 2). miRNA microarray performed on primary bron-
chial epithelial cells cultured at air-liquid interface (ALI)
showed higher expression of let-7f, miR-181c* and miR-
487b but lower expression of miR-203 in mild asthmatics
compared with healthy controls [121]. miR-203 has been
shown to play a potent role in the (keratinocyte) self-
renewal program during epidermal differentiation by target-
ing p63, facilitating cell cycle exit and promoting differenti-
ation [122]. Given that the epithelium of asthmatics
expresses higher levels of p63 [36], it is intriguing to specu-
late that there is a direct link between miR-203 and p63
(Fig. 2). Recently, miR-203 has also been shown to inhibit
airway smooth cell proliferation through targeting the non-
receptor tyrosine kinase c-Abl (Abelson tyrosine kinase,
Abl, ABL1) [123]. In particular, Abl kinases regulate cell-
cell adhesion in epithelial cells and fibroblasts through
cadherin-mediated adhesion signals via regulating the ac-
tivities of the Rac and Rho GTPases [124]. Since, c-Ab1
plays important roles in regulation of the actin cytoskel-
eton and hence different cellular functions such as prolif-
eration, cell adhesion and migration as well as growth and
development [123], the reduced level of miR-203 in epi-
thelial cells of asthmatics may promote cell proliferation,
increase goblet cell hyperplasia and/or decrease ciliated
cells. Genome wide profiling of bronchial epithelial brush-
ings also revealed four members of the miR-34/449 family
(miR-34b-5p, miR-34c-5p, miR-449a, and miR-449b-5p)
were significantly suppressed in asthma [125]. Interest-
ingly, no clear relationship was observed between
these differentially expressed miRNA and serum IgE
level in asthmatics [125], which indicates the role of
these miRNAs at cellular and molecular levels rather
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than inflammatory and allergic responses. Furthermore,
inhaled corticosteroids showed only minor effects on
miRNA expression, and failed to restore miRNA levels
to healthy control levels [125]. The miR-34/449 family
are closely associated with regulation of epithelial cell
proliferation and differentiation. Specifically, miR-449
is essential in regulation of airway ciliated cells by tar-
geting NOTCH1 [126]. Notch signaling triggers airway
mucous metaplasia and inhibits alveolar development
(ciliated cells) [127]. The low level of miR-449 in epi-
thelial cells of asthmatics may therefore shift the fate of
these cells toward more mucous production (Fig. 2).
Furthermore, miR-34/449-deficient mice suffer from
primary ciliary dyskinesia (PCD). These abnormalities
have been shown to be mediated by Cp110, a centriolar
protein suppressing cilia assembly, that is a target of
miR-34/449 [128]. A panel of miRNAs including miR-18a,
miR-27a, miR-128 and miR-155 were also down-regulated
in the epithelium of asthmatics. These miRNAs are in-
volved in activation/signaling of IL-6 and IL-8 [129].
Recently, miR-19a was reported to be the only miRNA
that differentiates severe from mild asthma. miR-19a is
up-regulated in severe asthmatic epithelial cells and is
not restored by corticosteroids [130]. Elevated levels of
miR-19a further stimulate cell proliferation of epithelial
cells by targeting TGF-β receptor 2 mRNA. Overexpres-
sion of miR-19a results in reduction in phosphorylated
SMAD3 whereas suppression of miR-19a facilitates
SMAD3 phosphorylation through TGF-β receptor 2
signaling and restore epithelial cells proliferation [130].
These may suggest the potential of miR-19a as a thera-
peutic target in airway epithelium of asthmatics to re-
establish epithelial regeneration.
There are limited numbers of investigations on miR-
NAs expression in asthmatic epithelium of children,
possibly due to difficulty in obtaining epithelial samples.
Higher level of miR-148b; a member of miR-152 family,
was reported in airway epithelial cells of adults with an
asthmatic mother and correlates with sHLA-G levels in
the BAL fluid of these subjects [131]. The prenatal effects
of maternal asthma on the regulation of foetal genes in
airway cells may persist well into adulthood through
miRNA regulatory mechanisms.
Other miRNAs in airway epithelium with potential role in
asthma development
Airway epithelial cells display dysregulted differentiation
in asthma. It is therefore important to investigate po-
tential miRNAs fundamental for lung development
and epithelial cell homeostasis such as miR-17 family
[132, 133]. miR-17 family consist of three paralog clusters
of miR-17–92 (miR-17-5p, miR-18, miR-19b, miR-20a,
miR-92, miR-19a and miR-17-3p), miR-106a–363 (miR-
106a, miR-18b, miR-20b, miR-19b-2, miR-92–2, and
miR-363), and miR-106b–25 (miR-106b, miR-93, and
miR-25) [134]. Among the miR-17 family, the miR-17-92
cluster and miR-106b have been shown to be essential in
maintaining of the structural homeostasis of developing
lung epithelium [132, 134]. miR-17-5p, miR-19b and miR-
20 are increased in the epithelium and mesenchyme of the
embryonic lung compared with fully developed lung [132].
Furthermore, miR-17, miR-20a and miR-106b modulate
fibroblast growth factor (FGF)10–FGFR2b signaling by
specifically targeting STAT3 and MAPK14, and altering
E-cadherin distribution. This is vital for epithelial bud
morphogenesis in response to FGF10 signaling [134].
Fig. 2 Role of miRNAs in airway epithelial cells regeneration. a In healthy airway epithelial cells, miR-449 suppresses NOTCH1 mRNA and encourages
differentiation of ciliated cells compared with goblet cells. miR-203 may paly essential role in epithelial cell homeostasis by suppressing p63 which is
expressed in basal cells. b The level of miR-449 and miR-203 are reduced in asthmatic airway epithelial cells, which may result in increase in goblet cells
and compromising epithelial cells regeneration, respectively. Solid lines and bold fonts represent strong effect and dashed lines and normal font
represent weak effect
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STAT3 and MAPK14 signalling play important roles in
airway homeostasis. STAT3 stimulates regeneration
and multiciliogenesis by inhibition of the Notch path-
way and direct regulation of genes such as Mcidas and
Foxj1 [135]. MAPK14 (known also as p38α) has also
been shown to regulate lung stem or progenitor cell
proliferation and differentiation [136]. MAPK14 regu-
lates C/EBP and HNF3b which are necessary for the
differentiation of the stem cells into AT2 and Clara
cells, while coordinately suppressing the regulators of
stem and progenitor cells proliferation; cyclin D1 and
EGFR [136]. These findings emphasise the role of these
signalling pathways as well as their regulatory miRNAs in
airway epithelial cells homeostasis, which is dysregulated
in asthma. These pathways may initiate development and
progression of asthma.
Conclusions
Overall, studies on asthma susceptibility genes (Table 1)
and epigenetic regulatory mechanisms (Table 2) of air-
way epithelial cells provide important insights in the de-
velopment and progression of asthma (Fig. 3).
Among susceptibility genes detected by positional
cloning (Table 1), IRAKM may represent a potential bio-
marker for early onset of asthma [26] whereas PCDH1
may be a potential biomarker in both children and
adults [22]. Although ADAM33 protein increases in epi-
thelium of asthmatics, it is not related to severity of dis-
ease [18]. None of the genes listed above can predict
specific endotypes of asthma. Some genes detected by
GWAS (Table 1) have shown the potential as asthma
biomarkers in a specific age group, e.g. ORMDL3/GSDMB
in children [60]. However, there is little overlap between
asthma susceptibility genes and their products detected
with positional cloning and GWAS. Epithelial eQTL could
detect more specific biomarkers for different phenotype of
asthma, such as CDHR3 associated with asthma in chil-
dren with severe exacerbation [78, 85], and CST1 [78],
which can differentiate asthmatic with EIB from those
with no EIB [84].
Asthma is a complex disease and it is unlikely that
limited functional genes are driving the entire patho-
physiological (immunological and structural) events.
Other challenges for genetic assessments are neglecting
Fig. 3 Overview of the key genes and epigenetic regulatory mechanisms associated with asthma in airway epithelial cells. Environmental insults
(e.g. allergens or viruses) may damage the integrity of airway epithelial cells. Some of the susceptibility genes expressed in the airway epithelial
cells (e.g. ADAM33) may further deteriorate this structural damage through the process of epithelial–mesenchymal trophic unit (EMTU) and hence
encouraging airway remodelling and hyper-responsiveness. Whereas other asthma susceptibility genes (e.g. IRAKM) may promote (Th2)-immunity
result in activation of inflammatory responses. Some of the genes have more protective roles (e.g. SPINK5 and TSLP). Furthermore, epigenetic
regulatory mechanisms may affect some of these genes (e.g. hyper-methylation of ADAM33, and HLA-G suppression by miRNAs)
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information for rare variants in some populations, clin-
ical heterogeneity of asthma and the effects of various
important environmental factors including smoking, air
pollution, and microbial exposures. Recent studies on
epigenetic regulatory factors (Table 2) have added new
insights to the field. Some of the DNA methylation sig-
natures in epithelial cells of asthmatics may be involved
in epithelial homeostasis (KRT5 and STAT5A), BHR
(ADAM33) and FeNO regulation (ARG2, IL-6 and iNOS)
[98–101]. Notably, ADAM33 is also a target of methylation
(Fig. 3) [101], which emphasises the importance of con-
comitant assessment genetic and epigenetic regulatory fac-
tors in airway epithelium of asthmatics. More profoundly,
miRNA networks have been shown to regulate a major por-
tion of post-transcriptional gene regulation [130].
There are however some challenges in interpretation
of miRNAs findings from different studies. One import-
ant factor is the origin of samples; for example bronchial
biopsies [137] compared with cultured primary epithelial
cells [121] or bronchial epithelial brushing that may in-
clude other cells which may affect yield and type of de-
tectable miRNAs [125]. Severity of disease [137] and
varying technologies and methods of analysis may also
play essential roles in outcomes of miRNAs quantifica-
tions. The most common technology used is microarray
which may ignore less abundant miRNAs and may not
distinguish miRNAs from other RNAs with similar se-
quences, such as other members of the same miRNA
family [125]. quantitative PCR is an alternative, which
does not necessarily measure all potentially biologically
important miRNAs. Additionally, the method to analyse
and present data; ΔΔCT [121, 129, 130] versus 2-ΔΔCT
[137], can affect the outcomes. One potential way to
overcome these inconsistencies is assessing miRNA ex-
pression in primary airway epithelial cells at air liquid
interface culture; a mimic of pseudostratified physio-
logical model, using technology such as NanoString that
counts individual miRNA with high accuracy.
Future prospects of miRNA research
While a number of miRNAs have been associated with
abnormalities in asthmatic epithelium and disease pro-
gression, current asthma treatments (e.g. corticosteroids)
show no major effect on them [125, 130, 137]. Seeking a
novel approach to target abnormally expressed miRNAs
and hence restoring their normal functions may provide
a novel asthma intervention strategy. Specific targeting
of miRNA clusters (e.g. miR-17-92 cluster with proposed
proliferative roles) may restore normal epithelial homeo-
stasis although off-target effects should to be carefully
evaluated. Further studies to identify specific miRNA-
mRNA interactions and validation of target proteins
important in asthma pathogenesis may provide potential
steps forward to providing important insights into the
development of potential intervention to reverse the epithe-
lial abnormities in asthmatics. Additionally, manipulating
epigenetic factors regulating miRNAs (e.g. re-expression of
miRNAs using demethylating agents to inhibit DNA
methylation of the miRNA promoter) may provide another
approach to restore miRNA abnormalities in asthmatics. It
is also important to clarify whether these differences in
miRNAs are the major factors driving asthma or if the
pathology of the disease induces these changes. Hence, add-
itional studies in larger cohorts are essential to distinguish
the effects of different asthma medications on the expres-
sion of miRNAs in bronchial epithelial cells.
Overall, there are interactions between genetic factors
and epigenetic regulatory mechanisms and assessment
of only one factor may not provide enough information.
miRNAs expression in conjunction with other epigenetic
regulatory factors may be an essential contributing factor
to asthma. Understanding the mechanisms that initiate
the development and progression of asthma, including
regulation of gene transcription or translation, are essen-
tial to identify potential targets in airway epithelium for
asthma intervention.
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